4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001012975-25-000592
Director acquired 1,740,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sessa Capital (Master), L.P. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-29 | Exercise or conversion : show line 1 in the form | +1,740,000 | $1.75 | $3,045,000 | 2,198,457 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-29 | Exercise or conversion : show line 2 in the form Series B Convertible Preferred Stock | −17,400 | 211,100 | D |
Loading xslF345X05/form4.xml…